326 related articles for article (PubMed ID: 21308778)
1. Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment.
Saeed H; Abdallah BM; Ditzel N; Catala-Lehnen P; Qiu W; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1494-505. PubMed ID: 21308778
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of telomere dysfunction phenocopy skeletal changes found in human age-related osteoporosis.
Brennan TA; Egan KP; Lindborg CM; Chen Q; Sweetwyne MT; Hankenson KD; Xie SX; Johnson FB; Pignolo RJ
Dis Model Mech; 2014 May; 7(5):583-92. PubMed ID: 24626990
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathway.
Saeed H; Qiu W; Li C; Flyvbjerg A; Abdallah BM; Kassem M
Biogerontology; 2015 Dec; 16(6):733-45. PubMed ID: 26260615
[TBL] [Abstract][Full Text] [Related]
4. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
6. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis.
Pignolo RJ; Suda RK; McMillan EA; Shen J; Lee SH; Choi Y; Wright AC; Johnson FB
Aging Cell; 2008 Jan; 7(1):23-31. PubMed ID: 18028256
[TBL] [Abstract][Full Text] [Related]
7. DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age.
Kim HN; Chang J; Shao L; Han L; Iyer S; Manolagas SC; O'Brien CA; Jilka RL; Zhou D; Almeida M
Aging Cell; 2017 Aug; 16(4):693-703. PubMed ID: 28401730
[TBL] [Abstract][Full Text] [Related]
8. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells.
Stenderup K; Justesen J; Clausen C; Kassem M
Bone; 2003 Dec; 33(6):919-26. PubMed ID: 14678851
[TBL] [Abstract][Full Text] [Related]
9. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
10. Microtubule assembly affects bone mass by regulating both osteoblast and osteoclast functions: stathmin deficiency produces an osteopenic phenotype in mice.
Liu H; Zhang R; Ko SY; Oyajobi BO; Papasian CJ; Deng HW; Zhang S; Zhao M
J Bone Miner Res; 2011 Sep; 26(9):2052-67. PubMed ID: 21557310
[TBL] [Abstract][Full Text] [Related]
11. Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes.
Biver G; Wang N; Gartland A; Orriss I; Arnett TR; Boeynaems JM; Robaye B
Stem Cells; 2013 Dec; 31(12):2747-58. PubMed ID: 23629754
[TBL] [Abstract][Full Text] [Related]
12. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.
Bennett CN; Ouyang H; Ma YL; Zeng Q; Gerin I; Sousa KM; Lane TF; Krishnan V; Hankenson KD; MacDougald OA
J Bone Miner Res; 2007 Dec; 22(12):1924-32. PubMed ID: 17708715
[TBL] [Abstract][Full Text] [Related]
13. Aberrant gene expression profiles, during in vitro osteoblast differentiation, of telomerase deficient mouse bone marrow stromal stem cells (mBMSCs).
Saeed H; Iqtedar M
J Biomed Sci; 2015 Jan; 22(1):11. PubMed ID: 25633569
[TBL] [Abstract][Full Text] [Related]
14. The p27 Pathway Modulates the Regulation of Skeletal Growth and Osteoblastic Bone Formation by Parathyroid Hormone-Related Peptide.
Zhu M; Zhang J; Dong Z; Zhang Y; Wang R; Karaplis A; Goltzman D; Miao D
J Bone Miner Res; 2015 Nov; 30(11):1969-79. PubMed ID: 25917430
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.
Elabd C; Basillais A; Beaupied H; Breuil V; Wagner N; Scheideler M; Zaragosi LE; Massiéra F; Lemichez E; Trajanoski Z; Carle G; Euller-Ziegler L; Ailhaud G; Benhamou CL; Dani C; Amri EZ
Stem Cells; 2008 Sep; 26(9):2399-407. PubMed ID: 18583541
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analysis of mesenchymal progenitors and bone quality in the stem cell antigen-1-null osteoporotic mouse.
Holmes C; Khan TS; Owen C; Ciliberti N; Grynpas MD; Stanford WL
J Bone Miner Res; 2007 Sep; 22(9):1373-86. PubMed ID: 17547535
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Alveolar Stem Cell Senescence, Apoptosis, and Differentiation by p53-Dependent and -Independent Mechanisms in Telomerase-Deficient Mice.
Zhang K; Wang L; Hong X; Chen H; Shi Y; Liu Y; Liu J; Liu JP
Cells; 2021 Oct; 10(11):. PubMed ID: 34831112
[TBL] [Abstract][Full Text] [Related]
19. N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging.
Haÿ E; Dieudonné FX; Saidak Z; Marty C; Brun J; Da Nascimento S; Sonnet P; Marie PJ
J Cell Physiol; 2014 Nov; 229(11):1765-75. PubMed ID: 24664975
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
